4.5 Review

Regulatory T cells and inhibitory cytokines in autoimmunity

Journal

CURRENT OPINION IN IMMUNOLOGY
Volume 21, Issue 6, Pages 612-618

Publisher

CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2009.09.011

Keywords

-

Categories

Funding

  1. Juvenile Diabetes Research Foundation International [1-2004-141, 3-2009-594]
  2. The Robert and Janice Compton Research [1-2006-847]
  3. NIH [A1072239]
  4. St Jude Cancer Center Support CORE [CA-21765]
  5. American Lebanese Syrian Associated Charities (ALSAC)

Ask authors/readers for more resources

Foxp3(+) regulatory T cells (T-regs) contribute significantly to the maintenance of peripheral tolerance, but they ultimately fail in autoimmune diseases. The events that lead to T-reg failure in controlling autoreactive effector T cells (T-effs,) during autoimmunity are not completely understood. In this review, we discuss possible mechanisms for this subversion as they relate to type 1 diabetes (T1D) and multiple sclerosis (MS). Recent studies emphasize firstly, the role of inflammatory cytokines, such as IL-6, in inhibiting or subverting T,g function; secondly, the issue of T-reg plasticity; thirdly, the possible resistance of autoimmune T cells to T-reg-mediated control; and fourthly, T-reg-associated inhibitory cytokines TGF beta, IL-10 and IL-35 in facilitating T-reg suppressive activity and promoting T-reg generation. These recent advances place a large emphasis on the local tissue specific inflammatory environment as it relates to T-reg function and disease development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available